Disease-free survival (DFS), hazard ratio (95% CI), P-value | Overall survival (OS), hazard ratio (95% CI), P-value | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IHC1 | H-Score2 | QPCR3 | IHC1 | H-Score2 | QPCR3 | |||||||
COX-1 / PTGS1 | ||||||||||||
N cases / eventsa | 47 / 15 vs 71 / 42 | 60 / 26 vs 58 / 31 | 15 / 12 vs 17 / 13 | 77 / 43 vs 113 / 77 | 95 / 57 vs 95 / 63 | 24 / 19 vs 25 / 18 | ||||||
Unadjusted | 2.34 (1.30–4.24) | 0.005 | 1.49 (0.88–2.50) | 0.138 | 1.77 (0.79–3.98) | 0.168 | 1.13 (0.78–1.65) | 0.515 | 1.09 (0.76–1.56) | 0.647 | 1.17 (0.61–2.23) | 0.641 |
Adjustedb | 1.58 (0.85–2.94) | 0.148 | 1.44 (0.85–2.43) | 0.180 | 4.12 (1.51–11.26) | 0.006 | 0.79 (0.54–1.16) | 0.227 | 0.97 (0.68–1.40) | 0.882 | 2.02 (0.96–4.22) | 0.063 |
Adjustedc | 1.55 (0.81–2.98) | 0.187 | 1.30 (0.75–2.34) | 0.356 | 6.37 (1.84–22.01) | 0.003 | 0.87 (0.59–1.30) | 0.495 | 1.14 (0.78–1.65) | 0.504 | 2.26 (1.04–4.91) | 0.039 |
COX-2 / PTGS2 | ||||||||||||
N cases / events | 50 / 33 vs 68 / 24 | 46 / 29 vs 72 / 28 | 10 / 10 vs 14 / 9 | 103 / 80 vs 87 / 40 | 95 / 72 vs 95 / 48 | 18 / 16 vs 18 / 11 | ||||||
Unadjusted | 0.51 (0.30–0.87) | 0.013 | 0.61 (0.36–1.02) | 0.061 | 0.51 (0.20–1.29) | 0.154 | 0.52 (0.36–0.77) | < 0.001 | 0.57 (0.39–0.82) | 0.002 | 0.59 (0.27–1.27) | 0.173 |
Adjustedb | 1.53 (0.85–2.76) | 0.160 | 1.93 (1.08–3.46) | 0.028 | 0.86 (0.30–2.45) | 0.772 | 0.85 (0.57–1.27) | 0.420 | 0.89 (0.61–1.31) | 0.559 | 0.77 (0.35–1.71) | 0.519 |
Adjustedc | 1.54 (0.84–2.80) | 0.161 | 1.92 (1.06–3.49) | 0.033 | 0.87 (0.31–2.47) | 0.798 | 1.05 (0.69–1.59) | 0.818 | 1.05 (0.71–1.56) | 0.802 | 1.40 (0.56–3.51) | 0.477 |